Swiss-Labsp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-08-29
Share capital
100,000.00 PLN
Activity description

Swiss-Lab offers private blood tests and laboratory packages without a referral, including thyroid tests, vitamin D testing, sexually transmitted disease tests, and health reviews for women and men. Customers can purchase tests online, visit a selected laboratory, and receive results online.

Registered address
Śmiała 30, 01-523 Warszawa, Poland
Opening hours
Monday–Friday
8:00–16:00
Phone
Social media

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 80 days late).

  • 202519/06/2026
  • 202415/07/2025
  • 202312/04/2024
  • 202207/06/2023
  • 202103/10/2022
  • 202014/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 394.87kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 39.26kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 351.28kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 482.27kMedianUSD 608.93kAverageUSD 11.85m

Offer

  • Blood tests
  • Laboratory tests
  • Test packages
  • Telemedicine consultations

Website technology

Analytics and marketing
  • Google Tag Manager

Trademarks

Swiss-Lab holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2024.

MarkNumberClassesStatusProtected until
SWISSLABZ.56594244Protected Feb 12, 2034
MarkProtected until
SWISSLABFeb 12, 2034

Authorized Representatives

Artur Michał Jasiński – President of the Management Board

Manner of representation

The persons authorized to make declarations of will and sign on behalf of the company are: in the case of a one-person management board, one member of the management board independently, and in the case of a multi-member management board, two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Ewelina Jasińskaage 45
100$13,506.2150%
Artur Michał Jasińskiage 49
100$13,506.2150%

Artur Michał Jasiński and Ewelina Jasińska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2013-04-04.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$280
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$280

Competitors

Name
Bio-Novumsp. z o.o.
Formedicsp. z o.o.
Red Med Polandsp. z o.o.
Labo Plussp. z o.o.
Zbadajsiesp. z o.o.
Medcellsp. z o.o.
Screenmedsp. z o.o.

FAQ

Last updated: 2026-07-13